CTT Pharmaceutical Holdings, Inc.(CTTH)
Pharmaceuticals
CNS / Psychiatry Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-17 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +8,300 | +0.11%7,845,956 | $0.06 | $457 | View SEC filing | |
| 2025-11-24 | CTT PHARMACEUTICAL HOLDINGS, INC. Director | Purchase | +200,000 | +5.66%3,734,003 | $0.04 | $8,000 | View SEC filing | |
| 2025-11-21 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +62,900 | +0.81%7,837,656 | $0.04 | $2,516 | View SEC filing | |
| 2025-10-31 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +7,000 | +0.09%7,774,756 | $0.06 | $420 | View SEC filing | |
| 2025-10-07 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +6,815 | +0.09%7,767,756 | $0.06 | $409 | View SEC filing | |
| 2025-09-23 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +44,085 | +0.57%7,760,941 | $0.04 | $1,984 | View SEC filing | |
| 2025-08-01 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +15,800 | +0.23%6,966,856 | $0.04 | $553 | View SEC filing | |
| 2025-07-08 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +8,000 | +0.12%6,951,056 | $0.03 | $240 | View SEC filing | |
| 2025-06-30 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +39,600 | +0.57%6,943,056 | $0.03 | $990 | View SEC filing | |
| 2025-06-23 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +16,100 | +0.23%6,903,456 | $0.03 | $403 | View SEC filing | |
| 2025-06-13 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +54,798 | +0.80%6,887,356 | $0.03 | $1,370 | View SEC filing | |
| 2025-06-09 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +82,158 | +1.22%6,832,558 | $0.05 | $4,108 | View SEC filing | |
| 2025-04-10 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +9,984 | +0.15%6,600,400 | $0.07 | $649 | View SEC filing | |
| 2025-03-31 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +15,510 | +0.24%6,590,416 | $0.05 | $776 | View SEC filing | |
| 2025-03-14 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +5,400 | +0.08%6,574,906 | $0.06 | $324 | View SEC filing | |
| 2025-03-10 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +11,950 | +0.18%6,569,506 | $0.09 | $1,076 | View SEC filing | |
| 2025-02-06 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +5,200 | +0.08%6,557,556 | $0.12 | $624 | View SEC filing | |
| 2024-11-26 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +23,346 | +0.40%5,818,846 | $0.06 | $1,401 | View SEC filing | |
| 2024-09-13 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +750 | +0.01%5,795,500 | $0.06 | $41 | View SEC filing | |
| 2024-09-11 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +1,100 | +0.02%5,044,750 | $0.06 | $61 | View SEC filing | |
| 2024-09-03 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +1,000 | +0.02%5,043,650 | $0.06 | $60 | View SEC filing | |
| 2024-08-27 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +550 | +0.01%5,042,650 | $0.06 | $33 | View SEC filing | |
| 2024-08-21 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +2,900 | +0.06%5,042,100 | $0.05 | $145 | View SEC filing | |
| 2024-08-15 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +1,300 | +0.03%5,039,200 | $0.04 | $52 | View SEC filing | |
| 2024-08-09 | CTT PHARMACEUTICAL HOLDINGS, INC. CEO | Purchase | +2,200 | +0.04%5,037,900 | $0.04 | $92 | View SEC filing |
1-25 of 59